Browse studies

Find your next paid study

27,300 recruiting studies available now

A Phase 1/2 Study of Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma

The main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and Tafasitamab in patients with mantle cell lymphoma. Anot…

Mantle Cell Lymphoma

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Alvaro Alencar, MDNCT06029309

Adapting Enhanced Supports to Improve Patient Adherence to Secondary Antibiotic Prophylaxis for Rheumatic Heart Disease

The goal of this clinical trial is to test the effectiveness and implementation of enhanced Secondary Antibiotic Prophylaxis (SAP) supports using a hybrid type…

Rheumatic Heart Disease in Children

Estimated

~$10 – $675

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT07666048

Patient-centered Precision Medicine Lab Result Communication for Older Adults - Validation and Refinement of an Existing Chronic Kidney Disease (CKD) Risk Model

This study aims to improve how lab results are communicated to older adults by refining a predictive model that uses electronic health record (EHR) data. The m…

Predictive Modeling

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, Los AngelesNCT06995365

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Background: After an allogeneic hematopoietic stem cell transplant (HSCT), the donor genome is found in the recipient s circulation and tissues. Post-HSCT re…

LeukemiaLymphomaHematologic Malignancy

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06856226

Observational

Facial Vascularized Composite Allotransplantation: A Prospective Interventional Study Evaluating Safety, Functional Outcomes, and Patient-Reported Psychosocial Outcomes

The primary objective of this study is to evaluate the 5-year (60-month) allograft survival rate of facial vascularized composite allotransplantation performed…

Facial Vascularized Composite AllotransplantationFunctional Recovery

Estimated

~$10 – $750

Actual pay is set by the research site.

Yale UniversityNCT07810764

Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy

This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Stu…

Hodgkin Lymphoma in RemissionLeukemia in RemissionLymphoblastic Lymphoma+4 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Children's Oncology GroupNCT01790152

Phase 4

AI-Powered Hepatitis C Single-Encounter Test-and-Treat

This study will evaluate a single-visit approach to hepatitis C treatment in patients seen in the emergency department. Participants with hepatitis C will rece…

HEPATITIS C (HCV)

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Patrick GraceNCT07793643

Observational

Effectiveness of Repositioning, Physical Therapy, and Cranial Remolding in Infants With Cranial Deformation

This study will examine how effective caregiver's repositioning strategies are in correcting an infant's deformational cranial shape, as well as the effectiven…

Deformational PlagiocephalyDeformational Posterior PlagiocephalyBrachycephaly+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas Southwestern Medical CenterNCT05917678

Observational

The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia "SF-NAV"

The purpose of this research is to see how personal financial burden (financial toxicity) related to cancer affects the overall health and quality of life by e…

Acute Myeloid Leukemia

Estimated

~$10 – $750

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT06945042

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Brenipatide in the Treatment of Adult Participants With IBS-D

The purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated, what side effects may occur, and the safety and efficacy in participant…

Irritable Bowel SyndromeDiarrhea

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Eli Lilly and CompanyNCT07545759

Fabry Disease Registry Protocol

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry …

Fabry Disease

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Genzyme, a Sanofi CompanyNCT00196742

Phase 4

A Continuation Protocol for Deucravacitinib in Patients With Patients With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

The purpose of this study is to allow the continued administration of Deucravacitinib in participants with Systemic Lupus Erythematosus (SLE) or Discoid and/or…

Systemic Lupus Erythematosus (SLE)Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Bristol-Myers SquibbNCT06875960